Miltefosine: issues to be addressed in the future

Berman, J. ; Bryceson, A. D. M. ; Croft, S. ; Engel, J. ; Gutteridge, W. ; Karbwang, J. ; Sindermann, H. ; Soto, J. ; Sundar, S. ; Urbina, J. A. (2006) Miltefosine: issues to be addressed in the future Transactions of the Royal Society of Tropical Medicine and Hygiene, 100 (1). S41-S44. ISSN 0035-9203

Full text not available from this repository.

Official URL: http://www.sciencedirect.com/science/article/pii/S...

Related URL: http://dx.doi.org/10.1016/j.trstmh.2006.02.009

Abstract

Future issues that need to be addressed for miltefosine are efficacy against non-Indian visceral leishmaniasis, efficacy in HIV-coinfected patients, efficacy against the many forms of cutaneous and mucosal disease, effectiveness under clinical practice conditions, generation of drug resistance and the need to provide a second antileishmanial agent to protect against this disastrous event, and the ability to maintain reproductive contraceptive practices under routine clinical conditions.

Item Type:Article
Source:Copyright of this article belongs to Elsevier Science.
Keywords:Visceral Leishmaniasis; Cutaneous Leishmaniasis; Mucosal leishmaniasis; Miltefosine; Resistance; Toxicity
ID Code:94549
Deposited On:07 Oct 2013 10:32
Last Modified:07 Oct 2013 10:32

Repository Staff Only: item control page